320
Participants
Start Date
October 31, 2025
Primary Completion Date
February 28, 2030
Study Completion Date
December 31, 2030
SBRT
Please refer to the current NCCN NSCLC guidelines for possible treatment options
Second-line standard of care therapy
Please refer to the current NCCN NSCLC guidelines for possible treatment options.
Mount Sinai Chelsea, New York
Mount Sinai West, New York
Mount Sinai Hospital, New York
Mercy Hospital, Cedar Rapids
HSHS Saint Elizabeth's Hospital, O'Fallon
Crossroads Cancer Center, Effingham
Decatur Memorial Hospital, Decatur
Saint Francis Medical Center, Cape Girardeau
Nebraska Medicine-Village Pointe, Omaha
Nebraska Medicine-Bellevue, Bellevue
University of Nebraska Medical Center, Omaha
University of Oklahoma Health Sciences Center, Oklahoma City
City of Hope Comprehensive Cancer Center, Duarte
City of Hope at Irvine Lennar, Irvine
Collaborators (1)
Alliance for Clinical Trials in Oncology
OTHER
ECOG-ACRIN Cancer Research Group
NETWORK
NRG Oncology
OTHER
SWOG Cancer Research Network
NETWORK
Canadian Cancer Trials Group
NETWORK